GlassScriptPhysician profile
Patrick L Gagnon
NPI 1083748214
$15,059.76
in general payments reported to CMS, 2019-2025
38 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 82% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,150 · 2022: $2,995 · 2023: $4,073 · 2024: $3,754 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,914.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,664.17 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $2,165.58 | 2021-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $1,583.44 | 2021-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $1,123.63 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $886.28 | 2021-2024 | Austedo Xr, Austedo |
| Axsome Therapeutics, INC. | $846.26 | 2023-2025 | Auvelity |
| Scilex Pharmaceuticals INC. | $803.97 | 2021-2025 | Ztlido |
| Sunovion Pharmaceuticals INC. | $688.11 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $576.81 | 2021-2024 | Ingrezza |
| Alkermes, INC. | $309.95 | 2021-2024 | Lybalvi, Aristada |
| Eisai INC. | $227.43 | 2021 | |
| Exact Sciences Corporation | $196.52 | 2023-2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $186.63 | 2022-2023 | Quviviq |
| Corium, LLC | $165.21 | 2022-2023 | Azstarys |
| Qol Medical, LLC | $159.03 | 2024 | Sucraid |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gagnon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.